Semler Scientific, Inc. (SMLR)
- Previous Close
26.62 - Open
26.23 - Bid 25.76 x 100
- Ask 26.12 x 200
- Day's Range
25.78 - 26.60 - 52 Week Range
22.82 - 53.38 - Volume
51,001 - Avg. Volume
78,893 - Market Cap (intraday)
182.175M - Beta (5Y Monthly) 0.89
- PE Ratio (TTM)
9.85 - EPS (TTM)
2.63 - Earnings Date May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
www.semlerscientific.comRecent News: SMLR
Performance Overview: SMLR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMLR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMLR
Valuation Measures
Market Cap
182.18M
Enterprise Value
125.14M
Trailing P/E
9.85
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.97
Price/Book (mrq)
2.54
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
5.30
Financial Highlights
Profitability and Income Statement
Profit Margin
30.19%
Return on Assets (ttm)
20.42%
Return on Equity (ttm)
32.29%
Revenue (ttm)
68.18M
Net Income Avi to Common (ttm)
20.58M
Diluted EPS (ttm)
2.63
Balance Sheet and Cash Flow
Total Cash (mrq)
57.2M
Total Debt/Equity (mrq)
0.23%
Levered Free Cash Flow (ttm)
11.41M